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A B S T R A C T
Background
Carpal tunnel syndrome is a common problem and surgical decompression of the carpal tunnel is the most effective treatment. After
surgical decompression, the palmar skin may be closed using either absorbable or non-absorbable sutures. To date, there is conflicting
evidence regarding the ideal suture material and this formed the rationale for our review.
Objectives
To assess the effects of absorbable versus non-absorbable sutures for skin closure after elective carpal tunnel decompression surgery in
adults on postoperative pain, hand function, scar satisfaction, wound inflammation and adverse events.
Search methods
We searched the following databases on 30 October 2017: the Cochrane Neuromuscular Specialised Register, CENTRAL, MEDLINE,
and Embase. We searched two clinical trials registries on 30 October 2017.
Selection criteria
We considered all randomised or quasi-randomised controlled trials comparing absorbable and non-absorbable sutures for skin closure
after any form of carpal tunnel decompression surgery in adults.
Data collection and analysis
The unit of analysis was the hand rather than the patient. We performed meta-analysis of direct comparisons to generate standardised
mean differences (SMDs) with 95% confidence intervals (CIs) in pain scores and risk ratios (RRs) with 95% CIs for dichotomous
outcomes, such as wound inflammation. The primary outcome was postoperative pain. Secondary outcomes included hand function,
scar satisfaction, scar inflammation and adverse events (complications). We assessed the quality of evidence for key outcomes using
GRADE.
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Main results
We included five randomised trials (255 participants). The trials were all European (UK, Republic of Ireland, Denmark and the
Netherlands). Where quoted, the mean age of participants was between 48 and 53 years. The trials measured outcomes between one
and 12 weeks postoperatively.
Meta-analysis of postoperative pain scores for absorbable versus non-absorbable sutures at 10 days following open carpal tunnel
decompression (OCTD) produced a SMD of 0.03 (95% CI -0.43 to 0.48; 3 studies, number of participants (N) = 137; I2 = 43%); the
SMD suggests little or no difference, but with a high degree of uncertainty because of very low-quality evidence. At 10 days following
endoscopic carpal tunnel decompression (ECTD), the SMD for postoperative pain with use of absorbable versus non-absorbable sutures
was -0.81 (95% CI -1.36 to -0.25; 1 study; N = 54); although the SMD is consistent with a large effect, the very low-quality evidence
means the results are very uncertain. Only the OCTD studies provided pain data at 6 weeks, when the SMD was 0.06 (95% CI -
0.72 to 0.84; 4 studies; N = 175; I2 = 84%), which indicates little or no evidence of difference, but with a high degree of uncertainty
(very low-quality evidence). The RR for wound inflammation using absorbable versus non-absorbable sutures after OCTD was 2.28
(95% CI 0.24 to 21.91; N = 95; I2 = 90%) and after ECTD 0.93 (95% CI 0.06 to 14.09; 1 study, N = 54). Any difference in effect
on wound inflammation is uncertain because the quality of evidence is very low. One study reported postoperative hand function but
found no evidence of a difference between suture types at two weeks (mean difference (MD) -0.10, 95% CI -0.53 to 0.33, N = 36),
with similar findings at six and 12 weeks. Only the ECTD trial reported scar satisfaction, with 25 out of 28 people reporting a ’nice’
result in the absorbable-suture group, versus 18 out of 26 in the group who received non-absorbable sutures (RR 1.29, 95% CI 0.97
to 1.72, N = 54). These findings are also very uncertain as we judged the quality of the evidence to be very low. All studies were at high
risk of bias for most domains. No trials reported adverse events.
Authors’ conclusions
It is uncertain whether absorbable sutures confer better, worse or equivalent outcomes compared to non-absorbable sutures following
carpal tunnel decompression, because the quality of evidence is very low. Use of absorbable suture eliminates the need for suture removal,
which could confer considerable savings to patients and healthcare providers alike. We need rigorously-performed, non-inferiority
randomised trials with economic analyses to inform choice of suture.
P L A I N L A N G U A G E S U M M A R Y
Absorbable versus non-absorbable stitches for closing the wound after carpal tunnel surgery
What is the aim of this review?
The aim of this Cochrane review was to compare absorbable and non-absorbable material for stitching the wound after carpal tunnel
surgery. We collected and analysed information on this question and found five relevant studies.
Key messages
Wedo not knowwhether absorbable or non-absorbable stitches are better for closing the wound after surgery for carpal tunnel syndrome
(CTS). The studies we found only provide very low-quality evidence, which does not allow a conclusion to be made.
Only one study reported on hand function and scar satisfaction after surgery, and none provided data on side effects. We have no
evidence of sufficient quality to assist choice of suture following surgery for CTS. However, absorbable stitches do not require removal
and so time and cost savings could be made.
What was studied in the review?
CTS is a common condition that may affect one or both hands, with symptoms such as tingling, numbness, and weakness of the thumb
and fingers. These symptoms are usually caused by pressure on the median nerve as it passes from the arm across the wrist into the
palm. The nerve goes through a tunnel at the wrist made up of wrist bones and a band of thick tissue. If the size of this tunnel is too
small for any reason, pressure on the nerve can lead to problems using the hand, and other symptoms of CTS.
The treatment of CTS is divided into non-surgical treatments (splints and steroid injections) and surgical treatments. Surgery for CTS
is the most common non-urgent hand operation. This minor surgery is usually performed under local anaesthetic. In open carpal
tunnel surgery the cut is large enough for the surgeon to see the carpal tunnel directly. In endoscopic carpal tunnel surgery, the surgeon
makes two small cuts in the wrist, one for surgical instruments and the other for a small camera. Typically, the skin is closed with
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stitches, which are either absorbed naturally by the body (absorbable) or have to be removed (non-absorbable). Absorbable stitches are
convenient, but some people think they might worsen scarring and inflammation. Non-absorbable stitches are believed to cause less
inflammation and a better scar, but their removal involves greater costs and inconvenience for the patient and healthcare system.
We wanted to assess the evidence to find out whether there was a difference between these two types of suture when used for CTS
surgery.
What are the main results of the review?
Following a thorough search, we found five studies (with a total of 255 participants) that compared these stitches. All the studies had
some problems in design or the way they were performed. The participants in four studies had open carpal tunnel surgery and in one
study they had endoscopic carpal tunnel surgery.
Due to the very-low quality of the evidence contributing to our analyses, it is uncertain whether there are differences between absorbable
and non-absorbable stitches for pain at 10 days or 6 weeks after surgery, hand function, scar satisfaction or wound inflammation. The
studies did not report side effects.
How up to date is this review?
The review authors searched for studies that were available up to 30 October 2017.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Absorbable sutures compared with non-absorbable sutures for carpal tunnel decompression after open carpal tunnel decompression surgery
Patients: adults undergoing primary carpal tunnel decompression by open carpal tunnel decompression
Intervention: absorbable sutures for wound closure
Comparison: non-absorbable sutures for wound closure
Setting : secondary care
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Non-absorbable su-
tures
Absorbable sutures
Postopera-
tive pain: early pain (10
days postoperatively)
VAS 0 to 10
Verbal report ing scale
No pain-m ild pain-mod-
erate pain-severe pain
(converted to numerical
scale (0 to 3, 3 to 6, 6
to 10)
- The mean postopera-
t ive VAS pain af ter
OCTD in the non-ab-
sorbable suture groups
was 0.03 SMD higher
(0.43 lower to 0.48
higher)
137 (3 RCTs) ⊕©©©
Very low1,2
SMD 0.03 (95%CI -0.43
to 0.48)
A SMD of 0.03 repre-
sents lit t le or no dif fer-
ence between groups3
It is uncertain whether
or not there is any dif -
ference in postopera-
t ive pain scores at 10
days because the qual-
ity of evidence is very
low
Postoperative
pain: late pain (6 weeks
postoperatively)
VAS 0 to 10
Verbal report ing scale
No pain-m ild pain-mod-
erate pain-severe pain
(converted to numerical
scale (0 to 3, 3 to 6, 6
to 10)
- The mean postopera-
t ive pain (6 weeks) af ter
open CTD in the non-ab-
sorbable suture groups
was
0.06 SMD higher
(0.72 lower to 0.84
higher)
175 (4 RCTs) ⊕©©©
Very low1,2
SMD 0.06 (95%CI -0.72
to 0.84)
A SMD of 0.06 repre-
sents lit t le or no dif fer-
ence between groups
It is uncertain whether
there is any dif ference
in postoperat ive pain
scores at 6 weeks be-
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cause the quality of ev-
idence is very low
Postoperative
hand function (2 weeks
postoperatively)
Mean
CTS-FSS score (scale
1 to 5, where higher
scores indicate worse
funct ion)
The mean FSS score
in the non-absorbable
suture group 2 weeks
postoperat ively was 1.
6
The mean FSS score 2
weeks postoperat ively
was 0.1 lower (0.53
lower to 0.33 higher)
- 36 (1 RCT) ⊕©©©
Very low1,4
MD -0.10, 95% CI -0.53
to 0.33)
It is uncertain whether
there is any dif ference
between groups in post-
operat ive hand funct ion
because the quality of
evidence is very low
MD at 6 and 12
weeks follow-up post-
operat ively were 0.00
(95% CI -0.39 to 0.39)
and 0.00 (95% CI -0.37
to 0.37)
Wound Inflammation
6 to 12 weeks follow-up
370 per 1000 843 per 1000 (89 to
1000)
RR 2.28 (0.24 to 21.91) 95
(2 RCTs)
⊕©©©
Very low1,4
It is uncertain whether
there is any dif ference
between groups in the
occurrence of postop-
erat ive wound inf lam-
mation because the
quality of evidence is
very low
Postoperative scar sat-
isfaction
- - - - - Not measured
Adverse outcomes in-
cluding wound infec-
tion, scar breakdown or
return to theatre
- - - - - Not measured
CI: conf idence interval; OCTD: open carpal tunnel decompression; RR: risk rat io; SD: standard deviat ion; SMD: standardised mean dif ference; VAS: visual analogue scale;
CTS-FSS: Carpal Tunnel Syndome Funct ional Status Scale
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Quality of Evidence Grades
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Downgraded twice based on study lim itat ions (lack of allocat ion concealment, and lack of blinding of part icipants and
assessors).
2Downgraded once for heterogeneity.
3Based on a rule-of -thumb guide to interpretat ion of SMD: 0.2 represents a small ef fect, 0.5 a moderate ef fect, and 0.8 a large
ef fect (Cohen 1988 in Higgins 2011).
4Downgraded twice for imprecision in the est imate and indirectness (non-linear scale).
6
A
b
so
rb
a
b
le
v
e
rsu
s
n
o
n
-a
b
so
rb
a
b
le
su
tu
re
s
fo
r
sk
in
c
lo
su
re
a
fte
r
c
a
rp
a
l
tu
n
n
e
l
d
e
c
o
m
p
re
ssio
n
su
rg
e
r
y
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
8
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
B A C K G R O U N D
Description of the condition
Carpal tunnel syndrome (CTS) is a constellation of symptoms
resulting from compression of the median nerve within a fibro-
osseous tunnel between the carpal bones and palmar fascia, at the
level of the wrist. The compression has various causes, which may
or may not be reversible. Symptoms usually include numbness
with ’pins and needles’ in the hand, as well as pain at the wrist
or in the arm, particularly at night. In advanced cases, sensation
may be entirely lost and the thenar musculature (the muscles at
the base of the thumb) may atrophy, resulting in severe functional
impairment.
Most people with CTS will ultimately require surgery, as the most
effective and definitive treatment for the condition is surgical de-
compression, which aims to relieve pressure on the nerve as it
passes through the carpal tunnel (Verdugo 2008). Indeed, carpal
tunnel decompression surgery is the most commonly performed
elective procedure on the hand (Wildin 2006).
Description of the intervention
In order to decompress the median nerve, the overlying compress-
ing tissue must be divided; this is traditionally performed via a lon-
gitudinal incision in the palm that extends distally, from the distal
wrist crease for approximately 3 cm to 5 cm. The surgeon divides
the skin, underlying fat, vessels and fascial layers in line with the
wound until the tunnel is opened and the median nerve is fully
exposed. Once the median nerve is decompressed, the skin alone
is re-approximated with sutures and the hand adequately dressed.
Some surgeons prefer to decompress the carpal tunnel in a mini-
mally invasive fashion through a smaller skin incisionwith or with-
out telescopic instruments; these is known as minimally invasive
or endoscopic carpal tunnel decompression (ECTD). Minimally
invasive surgery means that most of the dissection cannot be done
under direct vision, which poses a theoretical risk of inadvertent
injury to the palmar cutaneous and recurrent motor branches of
themedian nerve, as well as inadequate decompression. Both tech-
niques have advantages and limitations, though neither has been
shown to be superior (Sanati 2007; Vasiliadis 2014). Therefore,
most surgeons still adopt an open approach (open carpal tunnel
decompression, OCTD) with a larger incision, as this operation
is quicker and easier to perform (Beck 2007; Kohanzadeh 2012;
Vasiliadis 2014).
Whilst the procedural steps of open and endoscopic carpal tunnel
decompression surgery are largely consistent worldwide, there is
conflicting evidence and ongoing debate regarding the ideal type
of suture for closing the surgical incision in the palmar skin.
How the intervention might work
Some surgeons utilise absorbable sutures, which may be braided
or monofilament and carry different half-lives. Absorbable sutures
rely on tissue hydrolysis to disintegrate, with the remnants being
absorbed by phagocytes. The arguments for using absorbable su-
tures include that because a repeat visit is not required for suture
removal and the dressings can remain undisturbed for longer, pa-
tients may even manage the dressings themselves at home and so
satisfaction may be improved. There are also benefits for health
professionals and the healthcare system, in terms of inherent re-
ductions in clinical workload, resource utilisation and direct and
indirect costs. However, these hypotheses have not been tested.
Conversely, some surgeons prefer to use non-absorbable (usually
monofilament) sutures, which are inert materials so theoretically
cause less tissue trauma and foreign-body reaction. This is thought
to confer a more aesthetically pleasing scar. Monofilament sutures
carry a hypothetically lower risk of wound infection, although
there is no convincing evidence of this in relation to hand surgery.
Many randomised trials and observational studies have compared
non-absorbable and absorbable sutures for skin closure after carpal
tunnel decompression surgery, but no consensus has yet been
reached.
Why it is important to do this review
Carpal tunnel decompression surgery is the most commonly
performed elective procedure on the hand, with approximately
72,000 operations performed annually in the UK (Wildin 2006).
The use of a different suture to close the skin could affect the cost
of the overall treatment and outcome. Firstly, if all surgeons in the
UK used non-absorbable sutures then the direct cost to the health
care service for suture removal following carpal tunnel decom-
pression would be in excess of GBP 3 million annually (PSSRU
2016), which only takes into account the cost of a single Gen-
eral Practice Nurse appointment for suture removal and dressing.
This annual cost clearly does not account for other direct costs
(e.g. instruments or dressings) or indirect costs to patients such
as days off work, travel, etc. Therefore, if absorbable sutures are
shown to be comparable or better than non-absorbable sutures,
then substantial cost savings could be made. Secondly, surgical-
site complications (e.g. pain, inflammation or infection) can ad-
versely affect a person’s day-to-day life and impair hand function,
so if a simple alteration to the type of suture material used to close
the skin could improve objective outcomes or reduce the rate of
adverse events, then it is important to know.
In the early postoperative phase, healing can be complicated by
wound dehiscence with or without infection or haematoma for-
mation. Both situations can affect the underlying median nerve
either by exposing it to the environment-which may result in des-
iccation and thus irreversible damage-or through compression by
blood, pus, oedema, etc., similarly resulting in axonal loss. Wound
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dehiscence and exudative reactions may have additional adverse
effects on the flexor tendons by inducing tenosynovitis and ad-
hesions. Such adverse events can significantly impair hand func-
tion and adversely affect quality of life. These early adverse events
usually warrant hospital admission and surgical reintervention. To
avoid such undesirable outcomes, surgeons aim to use the most
effective method of skin closure.
Late wound adverse events are usually related to either a symp-
tomatic scar (which may be painful, tender, insensate or itchy)
or recurrence of compressive symptoms. Recurrent CTS requires
surgery and the wound is then prone to the same early compli-
cations as at initial operation. Late scar-related adverse events can
impact on quality of life and hand function, leading to a request for
revision surgery. The type of wound closure may influence these
late complications because absorbable sutures evoke an inflam-
matory reaction and may cause undesirable local tissue reactions.
Conversely, non-absorbable sutures stimulate a foreign body reac-
tion from the immune system, which may also dysregulate wound
healing.
For these reasons and the great uncertainty on the topic, a com-
prehensive evaluation of the ideal suture material for closing this
standard incision is needed to reduce surgical-site morbidity, im-
prove outcomes and make the best use of resources.
O B J E C T I V E S
To assess the effects of absorbable versus non-absorbable sutures
for skin closure after elective carpal tunnel decompression surgery
in adults on postoperative pain, hand function, scar satisfaction,
wound inflammation and adverse events.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) and quasi-RCTs
only. We included studies reported as full text, those published as
abstract only and unpublished data. We placed no restrictions on
language.
Types of participants
We included adults who had undergone primary open, mini-
mally invasive or endoscopic elective carpal tunnel decompression
surgery, as all such individuals require the skin incision to be closed
using sutures.
We excluded participants with the following comorbidities and
characteristics.
1. Children (those less than 18 years old). Elective carpal
tunnel decompression is an operation which is more common in
later life and the majority of cases will be in adults over the age of
18 years.
2. People who underwent other surgery simultaneously (e.g.
Dupuytren’s fasciectomy or trigger finger release at the same time
as carpal tunnel decompression), as this may confound the
outcomes.
3. People who underwent revision carpal tunnel
decompression, as this could confound the results.
Types of interventions
We included trials comparing absorbable suture materials (e.g.
Vicryl, Vicryl Rapide or Monocryl) with non-absorbable suture
materials (e.g. Prolene or Ethilon) available for commercial use.We
excluded other methods of skin closure such as staples, tissue glue
and suture strips (Steri-Strips) because they are not comparable to
sutures and moreover, not commonly used in this situation.
Types of outcome measures
Primary outcomes
Ourprimary outcomewas postoperative pain, subcategorised into:
1. early pain: reported by participants at approximately 10
days postoperatively;
2. late pain: reported by participants at approximately 6 weeks
postoperatively.
We have deviated from our protocol in the assessment of the pri-
mary outcome because we set out to compare patient-reported
pain in the short term (48 hours postoperatively), medium term
(two to seven days postoperatively) and long term (more than
seven days postoperatively). However, few studies reported pain
scores comprehensively enough to permit assessment of three time
points, and so we took a pragmatic decision to deviate from pro-
tocol to assess pain at 10 days and 6 weeks, which were common
time points in the included trials (see also Differences between
protocol and review).
We chose pain as our primary outcome because all early adverse
events (arguably) have the common symptom of pain, which if
substantial would stimulate people to seek medical consultation.
However, quantitative measurement of postoperative pain follow-
ing carpal tunnel syndrome (CTS) is difficult because there are
many types of pain, which may coexist (including pillar pain, scar
pain, tissue swelling and distension, hypersensitivity, etc.). There-
fore, in order to generate appropriate data, we accepted pain mea-
sured on any validated pain scoring tool (including visual analogue
scales (VAS) or Likert scales), and transformed the data for ap-
propriate comparison in accordance with the established literature
(Collins 1997).
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Secondary outcomes
1. Postoperative hand function as measured by any validated
hand tool, e.g. the Disabilities of the Arm, Shoulder and Hand
(DASH) questionnaire (Hoang-Kim 2011).
2. Scar satisfaction and wound inflammation as measured by a
validated scale, e.g. the Vancouver Scar Scale (Baryza 1995).
3. Postoperative adverse events, e.g. wound infection, wound
breakdown and return to theatre.
Search methods for identification of studies
Electronic searches
With an Information Specialist (AAG) within Cochrane Neuro-
muscular, we searched:
1. the Cochrane Neuromuscular Specialised Register (30
October 2017) Appendix 1;
2. the Cochrane Central Register of Controlled Trials
(CENTRAL) (30 October 2017, in the Cochrane Register of
Studies Web Online) Appendix 2;
3. MEDLINE (1966 to 30 October 2017) Appendix 3;
4. Embase (1980 to 30 October 2017) Appendix 4.
We also conducted a search of the US National Insti-
tutes for Health Clinical Trials Registry, ClinicalTrials.gov (
www.ClinicalTrials.gov) and the World Health Organization
International Clinical Trials Registry Portal (ICTRP) (http://
apps.who.int/trialsearch/) for ongoing incomplete trials or trials
which were completed and unpublished, using the term ’carpal
tunnel’. We searched all databases from their inception to the
present (30 October 2017), and imposed no restriction on lan-
guage of publication.
Searching other resources
We searched reference lists of all primary studies and review arti-
cles for additional references.We searched relevant manufacturers’
websites for trial information.
Data collection and analysis
Selection of studies
Two review authors (RGW and JCRW) independently screened
titles and abstracts of all the potential studies for inclusion and
coded them as ’retrieve’ (eligible or potentially eligible, or unclear)
or ’do not retrieve’.We retrieved the full-text study reports or pub-
lications and two review authors (RGW and JCRW) then inde-
pendently screened the full text. Studies were labelled for inclusion
or exclusion with explanations. We resolved any disagreements
through discussion or, if required, by consulting a third review
author (AF). We identified and excluded duplicates and collated
multiple reports of the same study so that each study, rather than
each report, was the unit of interest in the review. We recorded the
selection process in sufficient detail to complete a PRISMA flow
diagram (Figure 1) and ’Characteristics of excluded studies’ table.
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Figure 1. Flow diagram illustrating the study selection process.
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Data extraction and management
We used a data extraction form for study characteristics and out-
come data that had been piloted prior to conducting the review.
Two review authors (RGW and JCRW) independently extracted
data from included studies, including:
1. methods: study design, total duration of study, details of
any ’run in’ period, number of study centres and location, study
setting, withdrawals and date of study;
2. participants: number of participants, number of hands
randomised, number of bilateral cases, whether intervention
randomised to hand or participant, mean age, age range, gender,
severity of condition, diagnostic criteria, baseline characteristics,
handedness, medical comorbidity, inclusion criteria and
exclusion criteria;
3. interventions: intervention and comparison;
4. outcomes: primary and secondary outcomes specified and
collected and time points reported;
5. notes: funding for trial and notable conflicts of interest of
trial authors.
Both review authors (RGW and JCRW) then compared extracted
data for accuracy. One dataset was then discarded and the remain-
ing dataset used for the review. We noted in the ’Characteristics
of included studies’ table if outcome data were not reported in
a usable way. We resolved disagreements by consensus or by in-
volving a third review author (AF). One review author (JCRW)
then transferred data into Review Manager (RevMan 2012) and
a second review author (RGW) again independently checked all
entered data against the original trial reports for accuracy. No re-
ports required translation.
Assessment of risk of bias in included studies
Two review authors (JCRWandRGW) independently assessed the
risk of bias for each study using the criteria outlined in theCochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
We resolved any disagreements by discussion or by involving a
third review author (AF). We assessed the risk of bias according to
the following domains.
1. Random sequence generation
2. Allocation concealment
3. Blinding of participants and personnel
4. Blinding of outcome assessment
5. Incomplete outcome data
6. Selective outcome reporting
7. Other sources of bias, e.g. bias arising because of bilateral
cases
We graded each potential source of bias as high, low or unclear,
with a justification for our judgement in the ’Risk of bias’ table.We
summarised the risk of bias judgements across different studies for
each of the domains listed. We considered blinding separately for
different key outcomes where necessary (e.g. for unblinded out-
come assessment, risk of bias for all-cause mortality may be very
different than for a patient-reported pain scale). Where informa-
tion on risk of bias related to unpublished data or correspondence
with a trialist, we noted this in the ’Risk of bias’ table.
When considering treatment effects, we took into account the risk
of bias for the studies that contribute to that outcome.
Assessment of bias in conducting the systematic
review
We conducted the review according to the published protocol
and reported any deviations from it in the ’Differences between
protocol and review’ section of the systematic review.
Measures of treatment effect
We analysed dichotomous data as risk ratios and continuous data
as standardised mean difference in order that outcomes that were
conceptually the same (e.g. pain scores) but measured in different
ways (e.g. a VAS in one study and a Likert scale) could be con-
verted, standardised and pooled. For Erel 2001, we converted pa-
tient-reported pain which was recorded on a 4-point Likert scale
to a continuous metric in order to permit pooling as above and
applied the following conversions: no pain = 0, mild pain = 2.5,
moderate pain = 5, and severe pain = 7.5; this method is in accor-
dance with the literature (Collins 1997).
Unit of analysis issues
The unit of analysis was ’the hand’ rather than ’the participant’, as
wound complications are a local phenomenon and we were inter-
ested to know if they were linked to the suture type used. Where
studies considered simultaneous bilateral surgery, we included and
analysed the data if the hand was randomised and individual data
recorded for each side. Where an individual received different su-
tures on each hand and data per hand were not available or pro-
vided upon request, then we excluded the study.
Dealing with missing data
Wecontacted the corresponding authors of all eligible studies in or-
der to attempt to obtain missing data and clarify unclear method-
ology. When we received no response, we sent a second email to
the corresponding author. Thereafter, if we received no reply, we
contacted all the co-authors by email when their correspondence
details were publicly available.
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Assessment of heterogeneity
We used the I2 statistic to measure statistical heterogeneity among
the trials in each analysis and interpreted this statistic in accordance
with guidance in the Cochrane Handbook for Systematic Reviews of
Interventions (Deeks 2011).
Assessment of reporting biases
Had more than 10 trials been available, we planned to create and
examine a funnel plot to explore possibility of small-study biases.
Data synthesis
We used a random-effects model and performed a sensitivity anal-
ysis with a fixed-effect model. This decision was based on a pre-
liminary review of the available literature, which suggested hetero-
geneity between trials.
’Summary of findings’ table
We created a ’Summary of findings’ table using the following out-
comes.
1. Postoperative pain:
i) early pain: reported by participants at approximately
10 days postoperatively;
ii) late pain: reported by participants at approximately 6
weeks postoperatively.
2. Postoperative hand function.
3. Postoperative scar satisfaction.
4. Postoperative wound inflammation.
5. Postoperative adverse events, e.g. wound infection, wound
breakdown and return to theatre.
We used the five GRADE considerations (study limitations, con-
sistency of effect, imprecision, indirectness and publication bias)
to assess the quality of a body of evidence (studies that contribute
data for the prespecified outcomes). We used methods and rec-
ommendations described in Section 8.5 and Chapter 12 of the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2003; Higgins 2011), using GRADEpro software.
Subgroup analysis and investigation of heterogeneity
We planned to carry out the following subgroup analyses (Wade
2015).
1. Stratified by pre-operative severity of carpal tunnel
syndrome.
2. Stratified by medical comorbidity.
3. Stratified by unilateral versus bilateral carpal tunnel release
(to determine effect of participant-reported pain score).
We planned to use the following outcomes in subgroup analyses.
1. Postoperative pain.
2. Postoperative adverse events.
We would have used the formal test for subgroup interactions
in Review Manager (RevMan 2012) however, none of the above
variables were available to permit subgrouping.
Sensitivity analysis
We planned to carry out the following sensitivity analyses.
1. Repeat the analysis excluding unpublished studies (if there
were any).
2. Repeat the analysis excluding studies at high risk of bias
(non-blinded trials, high risk of bias from the method of
randomisation).
3. If there were one or more very large studies, repeat the
analysis excluding them to look at how much they dominate the
results.
4. Repeat the analysis excluding other types of studies, to
explore effects of decisions made during the review process.
None of the above criteria set out in our protocol were met; how-
ever, during data collection and analysis we identified the opera-
tive method as an important source of heterogeneity. Therefore,
we presented data from the ECTD trial separately (Hansen 2009).
This was a deviation from protocol (Wade 2015) which is dis-
cussed below in Differences between protocol and review..
R E S U L T S
Description of studies
Results of the search
From our searches, we identified 46 potential studies, of which
6 were from the Cochrane Neuromuscular Specialised Register,
8 were from CENTRAL,16 were from MEDLINE and 16 from
Embase. After we removed duplicate records, 24 articles remained
and we obtained them for assessment of eligibility. See Figure 1
for a flow chart illustrating the study selection process.
Included studies
See Characteristics of included studies.
We included five studies for meta-analysis (Erel 2001; Hansen
2009; Kharwadkar 2005; Menovsky 2004; Theopold 2012).
The two-group parallel randomised trial by Erel 2001 recruited 64
adults aged 18 to 80 years with carpal tunnel syndrome (CTS), un-
dergoing open carpal tunnel decompression (OCTD). One group
received a single deep subcutaneous absorbable 4-0 Vicryl suture
centrally and a completion continuous 4-0 Vicryl intradermal su-
ture for wound closure. The other group received interrupted 5-
0 Prolene sutures. The research took place in Hull, UK, over a
six-month period, although we do not know exactly when. The
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diagnostic criteria for CTS were not stated. The trial authors ex-
cluded those prone to poor wound healing (people taking corticos-
teroids, known to have “wound healing problems”) and pregnant
women. No hypothesis or primary outcome was stated. Outcomes
were assessed at 10 days and 6 weeks postoperatively. The authors
collected data on patient-reported pain using a Likert scale (one
to five) and the dichotomous outcomes of dehiscence, swelling,
inflammation, infection and haematoma. No attrition was de-
scribed. No funding source, conflicts of interest, or ethical review
was described.
Hansen 2009 conducted a two-group parallel, randomised trial of
58 hands (belonging to 50 participants) undergoing endoscopic
carpal tunnel decompression (ECTD) for CTS confirmed by elec-
trical studies. In one group the incision was closed with two inter-
rupted 5-0 non-absorbable Novafil sutures and the other with a
continuous intradermal 4-0 monofilament Caprosyn suture. The
study took place in Holstebro, Denmark, during 2006 to 2007.
Participants with bilateral CTS having bilateral surgery under-
went decompression on separate occasions and so were treated as
independent cases. Inclusion criteria were not stated. The trial-
ists appropriately excluded those with potential confounders for
local pain and impaired healing (diabetes mellitus, inflammatory
arthropathy and obesity), those ineligible for ECTD (due to prior
wrist fracture or revisional surgery), and pregnant women. We as-
sumed that the hand was the unit of randomisation but this is
not defined. The power calculation lacked integral statistics (the
desired alpha, beta and effect size) which precludes verification.
Participants recorded their pain on a visual analogue scale (VAS)
every day until follow-up at days 10 to 14. Participants recorded
scar satisfaction in private, three months postoperatively on a 5-
point ordinal scale (“very ugly”, “ugly”, “tolerable”, “nice” or “very
nice”). One participant withdrew from the trial on the day of
surgery owing to symptom resolution, and two were excluded as
the operation was converted to an open approach-we do not know
if they were excluded pre- or post-randomisation. One participant
was lost to follow-up and their data were excluded. The trial had
ethical approval. The report does not state authors’ conflicts of
interest, predilection for suture material or any funding for the
trial.
Kharwadkar 2005 was an ethically-approved, two-group, paral-
lel randomised trial on 40 hands (belonging to 33 participants)
with idiopathic CTS, treated with OCTD. In one group the inci-
sion was closed with 3-0 Vicryl and the other with 3-0 Prolene as
subcuticular sutures. The trial took place in Scunthorpe, UK, in
2003. The diagnostic criteria for CTS were: 1) pain, paraesthesia
or hypoaesthesia (or both) in the hand in the area innervated by
the median nerve; and 2) electrophysiological confirmation of the
diagnosis. The study included adults aged 18 to 75 years with CTS
according to the above criteria who could also complete written
questionnaires. The trialists excluded secondary CTS, those with
a potential “double-crush” (e.g. cervical radiculopathy or polyneu-
ropathy) and those with “wound healing problems”. The exclu-
sion criteria were prior wrist surgery or trauma, secondary CTS or
peripheral neuropathy, steroid use or “wound healing problems”.
No power calculation was provided. Participants completed vali-
dated questionnaires regarding their symptoms and function, the
(Boston)Carpal Tunnel Syndrome SymptomSeverity Scale (CTS-
SSS) and Functional Status Scale (CTS-FSS) and independent as-
sessments of outcomes were also undertaken at 2, 6 and 12 weeks
postoperatively. There are many issues with Boston questionnaire,
the foremost being that it is ostensibly not designed tomeasure the
function of the hand; it was developed to quantify the symptoms
of carpal tunnel syndrome (Levine 1993). Further: it is ambigu-
ous with respect to which hand is being measured (or whether it
measures both); it fails to adjust for unbalanced sided symptoms;
and the difference between categories is subjective and may not
be meaningful or externally valid. Presentation of these data as a
quantification of hand function may be misleading. Further, as
these outcome data are categorical, the authors should not present
means (with standard deviations (SDs)). The trialists’ methods
section explains that rank-based methods were used to analyse dif-
ferences; we assume that the correct rank-test was used for paired
and unpaired data, although this is not stated. The direction of
potential statistical bias cannot be confidently concluded. The trial
report does not describe conflicts of interest, funding or pre-exist-
ing suture preferences.
Menovsky 2004 conducted a three-group parallel, randomised
trial on 61 people with electromyographically proven idiopathic
CTS undergoing unilateral OCTD. In one group the skin was
closed with 4-0 Ethilon, one with 4-0 Vicryl and the other with
4-0 stainless steel based cable sutures; all in interrupted format.
No inclusion or exclusion criteria were described. They “ran-
domised” participants to one of three groups The outcomes of
pain (as measured on a 100-point VAS) and complications were
assessed at 10 days and six weeks postoperatively by the first au-
thor (TM) although the diagnostic criteria for “superficial wound
infection” or “posttraumatic dystrophy” were not stated. Addi-
tionally, hands were photographed postoperatively for indepen-
dent cosmetic analysis (comprising scar redness, granuloma forma-
tion and hypertrophy measured on a three-point scale of “none”,
“mild” and “severe”) but we do not know when the hands were
photographed, the conditions under which the images were ac-
quired or who assessed them. There was no description of a fund-
ing source, conflicts of interest, pre-existing suture preferences or
ethical review.
Theopold 2012 was a two-group parallel, randomised trial of 47
patients withCTS seeking open decompression atCorkUniversity
Teaching Hospital, Ireland. In one group the skin was closed with
4-0 Vircyl Rapide and the other with 4-0 Novofil as interrupted
sutures. We are not told when the trial took place. The inclusion
criteria and diagnostic criteria for CTS are not described. The trial
excluded patients undergoing revision surgery, those with an al-
lergy to suture materials, those prone to hypertrophic or keloid
scarring and people who were immunosuppressed. On the fourth
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postoperative day, participants were assessed for wound infection,
with the criteria being “any patient that was prescribed antibi-
otics for their wound”, but we do not know who reviewed the
wound, made the diagnosis or if this was a post hoc assessment.
On the 14th postoperative day, participants with non-absorbable
sutures had the material removed and the pain of this procedure
was scored on a VAS (ranging from 0 to 10) but again, we do not
know who recorded this score or the circumstances under which
it was measured. Six weeks postoperatively, scars were assessed us-
ing a validated scale (Patient and Observer Scar Assessment Scale
(POSAS)) by a surgeon blind to grouping, although again we do
not know the identity of this assessor. The POSAS, available at
www.posas.org, is an ordinal scale for various outcomes spanning
1 to 10. However, the authors report means and standard devia-
tions, and compare these outcome measures with “Students [sic]
t-test” which is not entirely appropriate. Ten categories cannot be
reliably approximated to the normal; a mean score is translatable
back to the category and we assume that such data is skewed,
so violating t-distribution methods. Rank-based methods would
have been more appropriate, with the presentation of median dif-
ferences and their spread. This raises concerns over the validity
of the statistical methods used because the method may influence
the effect estimate. A power calculation justified the trial authors’
sample size. Nine participants (23.7%) were lost to follow-up but
we do not know the group-specific rates. The trial does not de-
scribe funding, pre-existing suture preferences, conflicts of interest
or ethical review.
Excluded studies
See Characteristics of excluded studies. As literature on this topic
is very limited, we listed all papers assessed for inclusion, rather
than follow usual practice, which is to restrict Excluded studies to
reports of potentially randomised trials.
We excluded Freshwater 2012 andDellon 2001 because these were
letters to the editor in response to two included trials (Theopold
2012 and Erel 2001, respectively). We also excluded the case
reports by Acioly 2013, Hung 2008, Kokkalis 2015, Lu 2017
and Zingale 2003 as they were not applicable to our review. The
prospective studies byDosani 2013 andMacFarlane 2014 reported
the costs, healing profiles and clinical outcomes of absorbable ver-
sus non-absorbable sutures for skin closure following open carpal
tunnel decompression; however, neither were randomised trials
and so we excluded them. Although a potentially eligible study,
we had to exclude Kundra 2010 because it included patients un-
dergoing numerous different hand operations (trigger finger re-
lease, Dupuytren’s excision and carpal tunnel surgery) which were
randomised to compare the aesthetic outcomes of absorbable and
non-absorbable sutures only; they did not record any outcomes of
relevance to this review. The investigators reported scar outcomes
for the entire sample; therefore, we wrote to the authors request-
ing data specific to carpal tunnel decompression surgery and any
other outcomes which may have been recorded (no protocol is
provided to cross-check) and although the first author replied, the
original data were not available and so we were obliged to exclude
the trial. We excluded the review articles by Scholten 2012 and
Jerosch-Herold 2006 because they contained no primary outcome
data. We excluded the case series by Nassar 2014 and Kokkalis
2016 as they described the use of a synthetic biofilm after revision
OCTD.Ramos-Zúñiga 2017 reported the outcomes a series of pa-
tients undergoing ECTD and so was not applicable. We excluded
Lattré 2016 as this described their experience with OCTD and
the hypothenar fat pad flap. We excluded Magalhães 2017 as this
systematic review had similar aims to our review; we cross-checked
their references and found that we had screened all the same ci-
tations except Bolster 2013, which we excluded as this trial com-
pared different formats of suture (interrupted versus vertical mat-
tress) after OTCD. The case series by Tosti 2017 was excluded as
this considered catheter-associated radial artery pseudoaneurysms.
Risk of bias in included studies
All studies were subject to risks of bias, and lacked important in-
formation about the study design and execution.We contacted the
corresponding authors of all eligible studies in order to attempt to
obtain missing data and clarify unclear methodology. The authors
of Hansen 2009 replied and clarified our questions. We received
no replies from the authors of other included studies (Erel 2001;
Kharwadkar 2005; Menovsky 2004; Theopold 2012). See Figure
2 for a summary of ’Risk of bias’ judgements.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Both Kharwadkar 2005 and Theopold 2012 used sealed opaque
envelopes to conceal allocation (presumably from participants,
although not explicitly stated, because blinding the surgeon would
not be possible), and so we judged these studies to have low risk
of allocation bias. The risk of bias from the method of random
sequence generation was low in Kharwadkar 2005, but unclear in
Theopold 2012, as the report did not provide details.
We judged Hansen 2009 to have unclear risk of selection bias,
as methods of randomisation and allocation concealment were
inadequately described.We judged Erel 2001 andMenovsky 2004
as having unclear risk of bias from the method of randomisation
and high risk of bias from unconcealed allocation.
Blinding
We assumed that blinding of participants and interviewers did not
take place in Erel 2001, since these procedures were not described.
Also Erel 2001 did not describe how outcomes were assessed, e.g.
who determined the presence or absence of residual inflammation.
This is particularly concerning given that “data were collected by
telephone interview where possible”. Also, the paper does not de-
tail how the outcome of residual pain was measured, i.e. a mildly
sore hand after substantial activity in the absence of analgesia is
not the same as significant rest pain in the hand despite the use
of opioid analgesia. We considered the trial at high risk of perfor-
mance and detection bias.
WhilstHansen 2009 didnot qualify how they assessed for the pres-
ence of infection postoperatively, it is reasonable to deduce that an
appropriately qualified healthcare professional with experience in
hand surgery could reliably identify this adverse outcome. More
importantly, we do not know if the same nurse removed the su-
tures and measured the outcome of infection. Similarly, this study
states that the questionnaire regarding cosmesis was completed
and placed into a closed envelope, but it is again unclear whether
participants or researchers were blinded to the collected data and
whether statistical analysis was undertaken with knowledge of the
grouping. Therefore, we have judged the risk of performance bias
as unclear (given the lack of information on participant blinding)
and the risk of detection bias as unclear (for the same reason).
In Kharwadkar 2005, participants completed validated question-
naires regarding their hand function postoperatively and indepen-
dent assessments of outcomes were also undertaken at 2, 6, and 12
weeks postoperatively. However, it is not clear whether the asses-
sors were blinded to the intervention. The authors did not declare
any conflicts of interest.
In the three-group trial by Menovsky 2004, performance bias was
likely as blinding was unclear and detection bias was possible for
pain and numbness outcomes, given that the lead author and
operating surgeon undertook the postoperative evaluation of these
symptoms. Conversely, an independent group of four unnamed
persons performed assessments of aesthetic outcomes based on
photographs. This mixed picture led us to assign a judgement of
’unclear’ risk of detection bias.
The data fromTheopold 2012 are at high risk of performance and
detection bias. Participants were not blinded and it is unclear who
obtained the patient-reported pain data on the 14th postoperative
day; however, it is reasonable to assume that the methods were
consistent and patient-reported data from the 14th postoperative
day is at high risk of bias. Data obtained six weeks postoperatively
was via assessors blind to grouping. Overall we judged there to be
a high risk of performance and detection bias given the majority
of data (and those we have used) were obtained from unblinded
participants and assessors.
Incomplete outcome data
Erel 2001 had no responses from six participants (9.4%) at 10 days
for their primary outcome of pain, and had at least four dropouts
(6.3%) at six weeks. We assessed the trial as having unclear risk of
attrition bias. There was a high dropout rate (19%) in Theopold
2012 and so we assigned a judgement of ’unclear’ risk of bias in
this domain. Four people dropped out for reasons unrelated to the
interventions in Hansen 2009. We considered this to represent a
low risk of bias. Other studies reported complete data.
Selective reporting
The risk of selective outcome reporting by trial participants was
high in Erel 2001 as numerical results were not reported for
some outcomes, and unclear in Hansen 2009. We also assessed
the other three trials as ’unclear’ risk because there were no pub-
lished protocols to which we could compare the published articles
(Kharwadkar 2005; Menovsky 2004; Theopold 2012).
Other potential sources of bias
The contact author of Hansen 2009 confirmed in communication
with review authors that the trialists had no conflicts of interest
and that the trial was unfunded. He also declared a preference for
absorbable sutures.
In Erel 2001 the Chi2 test was incorrectly used for some com-
parisons as they violated the assumptions that < 20% of expected
counts are < 5. Ideally, they would have used exact methods (or
resampling, also known as bootstrapping) as a wrongly used test
of proportional difference is more likely to find a significant dif-
ference where none exists. We are unsure how the presumed con-
tinuous variable of ’weeks off work’ was analysed but this is not
an outcome in this review.
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We assessed the risk of ’other bias’ as unclear for Theopold 2012.
The study reported no conflicts of interest and no specific fund-
ing, however, trialists did not provide information on pre-existing
suture preference.
Kharwadkar 2005 and Menovsky 2004 did not describe conflicts
of interest or individual preferences for suture type and these omis-
sions weaken the reliability of the results; we therefore assessed
them as at unclear risk of bias. We feel that it is important for sur-
geons to state their prior biases, especially when outcome assess-
ment is unblinded. This is because some surgeons may prefer one
suture material over another and this could bias the assessment of
outcomes.
Effects of interventions
See: Summary of findings for the main comparison Absorbable
versus non-absorbable sutures for skin closure after open
carpal tunnel decompression surgery; Summary of findings 2
Absorbable versus non-absorbable sutures for skin closure after
endoscopic carpal tunnel decompression surgery
Absorbable versus non-absorbable sutures after open
carpal tunnel decompression (OCTD)
Primary outcome: postoperative pain
Postoperative pain at 10 days
This outcome was reported in Erel 2001, Kharwadkar 2005 and
Menovsky 2004.
Ten days after OCTD, the standardised mean difference (SMD)
in pain in absorbable versus non-absorbable suture groups was
0.03 (95% confidence interval (CI) -0.43 to 0.48; 3 randomised
controlled trials (RCTs), number of participants (N) = 137; I2 =
43%), as shown inAnalysis 1.1 and Figure 3. As a rule of thumb, an
SMD of less than 0.2 indicates no clear difference (Higgins 2011).
The I2 suggests moderate heterogeneity, probably arising from
variation in surgical techniques and outcome measures. Analyses
using fixed-effect instead of the random-effects model had little
effect on the findings. We judged the quality of the evidence to be
very low according to GRADE criteria, as shown in Summary of
findings for the main comparison.
Figure 3. Forest plot of comparison: 1 Absorbable versus non-absorbable sutures: open and endoscopic
carpal tunnel decompression, outcome: 1.1 Postoperative pain (10 days) after CTD.
Postoperative pain at 6 weeks
This outcome was reported in four trials of wound closure fol-
lowing OCTD (Erel 2001; Kharwadkar 2005; Menovsky 2004;
Theopold 2012). The SMD in pain in absorbable versus non-ab-
sorbable suture groups indicated little or no difference between
suture types at six weeks (SMD 0.06, 95% CI -0.72 to 0.84; 4
trials, N = 175; I2 = 84%; Analysis 1.2, Figure 4). The I2 suggests
substantial heterogeneity, probably arising from variation in surgi-
cal techniques and outcome measures. Analyses using fixed-effect
versus random-effects models had little effect on the findings. The
quality of evidence was very low (Summary of findings for the
main comparison).
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Figure 4. Forest plot of comparison: 1 Absorbable versus non-absorbable sutures: open and endoscopic
carpal tunnel decompression, outcome: 1.2 Postoperative pain (6 weeks) after open CTD.
Secondary outcomes
Postoperative hand function
Kharwadkar 2005 (N = 36) was the only study to report hand
function, which was measured using the Carpal Tunnel Syndome
Functional Status Scale (CTS-FSS). The report provided mean
scores and standard deviations (SDs) for each group pre-opera-
tively, at 2weeks (MD-0.10, 95%CI -0.53 to 0.33), 6 weeks (MD
0.00, 95% CI -0.39 to 0.39), and 12 weeks (0.00, 95% CI -0.37
to 0.37), suggesting no differences between the groups (Analysis
1.3). The evidence is very low quality (Summary of findings for
the main comparison).
Scar satisfaction and wound inflammation
Data for this outcome were provided in Kharwadkar 2005 and
Erel 2001.
The risk ratio (RR) forwound inflammationwith use of absorbable
versus non-absorbable sutures after OCTD was 2.28 (95% CI
0.24 to 21.91; 2 RCTs, N = 95; I2 = 90%), favouring non-ab-
sorbable sutures (Analysis 1.4; Figure 5). The I2 suggests substan-
tial heterogeneity, probably arising from variation in surgical tech-
niques and outcome measures. The quality of evidence was very
low (Summary of findings for the main comparison).
Figure 5. Forest plot of comparison: 1 Absorbable versus non-absorbable sutures: open and endoscopic
carpal tunnel decompression, outcome: 1.3 Wound inflammation.
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Scar satisfaction was not measured.
Postoperative adverse events
We were unable to perform a narrative review or pooled analysis
of postoperative and adverse events as these outcomes were not
reported in the included studies.
Absorbable versus non-absorbable sutures after
endoscopic carpal tunnel decompression
Primary outcome: postoperative pain
Postoperative pain at 10 days
Reported in Hansen 2009; the SMD for pain scores in the ab-
sorbable versus non-absorbable suture groups 10 days postoper-
atively after ECTD was -0.81 (95% CI -1.36 to -0.25; 1 RCT,
N = 54) (Analysis 2.1 and Figure 3). Using a rule of thumb for
SMD interpretation, this is a large effect in favour of absorbable
sutures. According to GRADE criteria, we judged the quality of
this evidence to be very low, as shown in Summary of findings 2.
Postoperative pain at 6 weeks
The ECTD study did not provide data for this outcome.
Secondary outcomes
Postoperative hand function
Not measured.
Scar satisfaction and wound inflammation
Reported in Hansen 2009; the RR for wound inflammation with
use of absorbable versus non-absorbable sutures after ECTD was
0.93 (95% CI 0.06 to 14.09; 1 RCT, N = 54) (Analysis 2.2 and
Figure 5). We judged the quality of this evidence to be very low,
as shown in Summary of findings 2.
Participants in Hansen 2009 recorded scar satisfaction three
months after the operation on a five-point ordinal scale (“very
ugly”, “ugly”, “tolerable”, “nice” or “very nice”). In the absence
of results from a validated scale we have reported the findings.
The trial reported that 25 out of28 participants in the absorbable-
suture group judged the scar to have a nice appearance compared
with 18 out of 26 in the non-absorbable suture group (RR 1.29,
95% CI 0.97 to 1.72; 1 RCT, N = 54) (Analysis 2.3). One person
in the group given non-absorbable sutures reported that the scar
was ugly or very ugly, compared with none in the group given
absorbable sutures. We judged the quality of evidence very low, as
shown in Summary of findings 2.
Postoperative adverse events
Wewere unable to perform a narrative review or pooled analysis of
postoperative adverse events as these outcomes were not reported
in the included studies.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Absorbable sutures compared with non-absorbable sutures for endoscopic carpal tunnel decompression
Patients: adults undergoing primary carpal tunnel decompression by endoscopic carpal tunnel decompression
Intervention: absorbable sutures for wound closure
Comparison: non-absorbable sutures for wound closure
Setting: secondary care
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Non-absorbable su-
tures
Absorbable sutures
Postopera-
tive pain: early pain (10
days postoperatively)
VAS 0 to 10
Verbal report ing scale
No pain-m ild pain-mod-
erate pain-severe pain
(converted to numerical
scale (0 to 3, 3 to 6, 6
to 10)
- The mean postopera-
t ive VAS pain af ter
ECTD in the non-ab-
sorbable suture groups
was 0.81 SMD lower (1.
36 to 0.25 lower)
54 (1 RCT) ⊕©©©
Very low1,2
SMD -0.81 (95% CI -1.
36 to -0.25)
A SMD of -0.81 repre-
sents a large dif ference
between groups.3
It is uncertain whether
or not there is any dif -
ference in postopera-
t ive pain scores at 10
days because the qual-
ity of evidence is very
low
Postoperative
pain: late pain (6 weeks
postoperatively)
- - - - - Not measured
Postoperative hand
function
- - - - Not measured
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Wound Inflammation
6 to 12 weeks follow-up
38 per 1000 36 per 1000
(2 to 542)
RR 0.93 (0.06 to 14.09) 54 (1 RCT) ⊕©©©
Very low1,2
It is uncertain whether
there is any dif ference
between groups in the
occurrence of postop-
erat ive wound inf lam-
mation because the
quality of evidence is
very low
Postoperative scar sat-
isfaction
692 per 1000 893 per 1000 (672 to
1000)
RR 1.29 (0.97 to 1.72) - ⊕©©©
Very low1,4
Adverse outcomes in-
cluding wound infec-
tion, scar breakdown or
return to theatre
- - - - - Not measured
CI: conf idence interval; ECTD: endoscopic carpal tunnel decompression; RR: risk rat io; SD: standard deviat ion; SMD: standardised mean dif ference; VAS: visual analogue scale
Quality of Evidence Grades
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Downgraded twice for study lim itat ions (lack of allocat ion concealment, and lack of blinding of part icipants and assessors).
2Downgraded twice for imprecision in the est imate, and indirectness.
3Based on a rule-of -thumb guide to interpretat ion of SMD: 0.2 represents a small ef fect, 0.5 a moderate ef fect, and 0.8 a large
ef fect (Cohen 1988 in Higgins 2011).
4Downgraded once for imprecision in the est imate and for indirectness (an ordinal scale, not stated to be validated).
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D I S C U S S I O N
Summary of main results
This review included five trials (255 randomised participants)
comparing absorbable and non-absorbable sutures, with various
surgical techniques to decompress the carpal tunnel and then close
the skin.
It is uncertain whether there is any difference in the outcomes fol-
lowing skin closure with absorbable versus non-absorbable sutures
after open or endoscopic carpal tunnel decompression surgery
(OCTD and ECTD, respectively). We chose pain as the primary
outcome as this is the most commonly reported outcome, all ad-
verse events (are likely to) manifest with pain in the hand and
anecdotally, surgical trainees are taught that absorbable sutures
cause more inflammation and so, pain. However, some readers
may question the utility of pain as an outcome in the study of skin
closure after CTD and the effect of suture material. It remains un-
clear whether suture material has any meaningful effect on post-
operative pain following OCTD or ECTD and whether this as-
sociation is direct or acts via other factors (e.g. occult infection,
foreign-body reaction to retained suture material, or otherwise).
We were seeking to add to the literature and help to clarify this
uncertainty in this review, but as the quality of the evidence on
this topic is very low, no reliable conclusions can be drawn with
respect to the outcomes of postoperative pain.
By eliminating the need for suture removal, patients avoid future
hospital or general practice appointments, which has the potential
to save over GBP 3 million per year in the UK, which is based
upon the direct cost of a nurse appointment for suture removal
in a GP practice (PSSRU 2016). The cost saving would likely be
much greater once other direct costs, of instruments, dressings,
protective equipment, and infrastructure, are considered, as well
as the speculative indirect cost savings for patients. Additionally,
by giving the patient autonomy in their wound care they can be
instructed to remove their own dressings at home (after a specified
period of time), thoroughly wash their own hand(s) and redress
as needed. Some readers may argue that the externalised knots of
absorbable sutures require removal by a professional, which we
accept; however, provided people are warned of this possibility,
they can seek an appointment on their own terms, which again
may confer fiscal savings.
Overall completeness and applicability of
evidence
Despite an analysis of five randomised trials directly comparing ab-
sorbable and non-absorbable sutures for carpal tunnel closure, we
were unable to confidently reach any clinically useful conclusions
on whether outcomes differ between these interventions. This is
primarily due to the high risk of bias of each included trial. There
is no robust evidence to support the use of one suture material over
the other in terms of postoperative outcomes. A rigorous, well-de-
signed non-inferiority randomised trial of absorbable versus non-
absorbable suture for carpal tunnel closure following decompres-
sion is indicated. The justification of a future trial should be based
on the findings of our review and avoid the methodological flaws
of the included studies. Scar satisfaction and postoperative hand
function were each reported in one trial and no trials reported
adverse events. Studies should report on all outcomes of relevance
as described above.
Two trials used only interrupted sutures (Menovsky 2004;
Theopold 2012), whilst the other three used a combination of
subcuticular and interrupted sutures (Erel 2001; Hansen 2009;
Kharwadkar 2005). At this point we should highlight that we
assume “subcuticular”, “intradermal” and “subcutaneous” sutures
are all comparable, as each study uses different terminology. We
take these terms to mean that the substance of the suture resides
entirely within the dermis. Nonetheless, this is a potential con-
founding variable both for the individual trials and for our pooled
analysis as each suture will manipulate the glabrous skin of the
hand within the longitudinal crease of the ring ray differently so,
for example, a mattress suture may evert the skin edges, an intra-
dermal suture may align them neutrally, and a simple interrupted
suture may achieve neutrality, inversion, or eversion of the skin
edges depending on the surgeon’s technique. Further, data from
Kharwadkar 2005 is substantially different to the other trials, as
shown in Figure 4; it is unclear why this study is an outlier but the
only notable difference is that the quality of this trial was supe-
rior to all other studies and that they used subcuticular suturing,
which is uncommon in hand surgery given that such a technique
is more challenging on the palmar skin. Future studies should aim
to compare the same format of suture (e.g. mattress only) and
only differ in the suture material. Furthermore, most articles lack
details about the suturing method, for example how sutures were
secured (i.e. buried knots versus externalised knots versus loose
ends with no knot), the type of needle used, etc., which prevents
the application of the findings to clinical practice.
Our review did not consider a number of other outcomes from
carpal tunnel surgery of interest to hand surgeons, patients and
policy makers. Effective allocation of healthcare resources depends
on cost-effectiveness data. We were interested in the fiscal impacts
of suture choice but, in the design phase of this review, agreed
by consensus that the effectiveness and side-effect profile of each
suture material should be established first. Accordingly, cost out-
comes did not feature as an outcome of interest in our protocol
and, in fact, none of the included studies reported cost outcomes.
Whilst our protocol was designed to capture serious adverse events,
interventions in hand surgery are often designed to hasten return
to usual activities of daily living or work. In common with the
authors of the Cochrane Review of rehabilitation interventions
following carpal tunnel release (Peters 2016), we consider an ad-
equately powered return-to-work analysis unlikely given the high
success rate of carpal tunnel surgery and the heterogeneity of trials,
outcome definition and timing. Nevertheless, future versions will
include return to work or usual activities as a secondary outcome,
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along with cost and quality of life, so that available data can be
included. A further change in future versions will be specification
of serious and rare adverse events, such as complex regional pain
syndrome.
Quality of the evidence
Overall, the quality of evidence is very low; consequently the find-
ings of our review are of limited transferability. To qualify this
statement and descriptions in our Summary of findings for the
main comparison and Summary of findings 2, we expand upon
these reasons below.
• Risk of bias-with the exception of Kharwadkar 2005, all
studies were at high or unclear risk of numerous biases based on
deficiencies in the published manuscripts, such as: failure to
describe the details of the randomisation and allocation, lack of
blinding of participants or outcome assessors, missing data due
to attrition and the omission of statements of conflicts of interest
and funding. All trials were conducted (and likely accepted for
publication) prior to the genesis of the trial reporting guidance,
therefore this information may exist but we were unable to
clarify such details with authors and so accordingly, we
downgraded the evidence twice.
• Inconsistency-all studies yield widely different estimates of
the effect of absorbable versus non-absorbable sutures on pain
after OCTD at 10 days, which could be a manifestation of
heterogeneity of the intervention or of the outcome
measurement; therefore, as a body of evidence, we have
downgraded it once.
• Indirectness-the pooled evidence comes from a variety of
sources, using different sutures in unknown configurations and
assessed using different outcome measures. We also question the
statistical analysis of non-linear measurement scales used for
assessment of symptom and function. Therefore, we have
concern over the generalisability of the data.
• Imprecision-the sample sizes of all studies were small and
the number of adverse events small too, so the confidence
intervals (CIs) are all very wide. Conventional power calculations
to detect a difference in means for the primary outcome of pain
(according to the means in the included studies), with 90%
power and a 5% level of significance, would warrant more than
1000 participants per study. Given that our review includes just
255 participants, we have downgraded the evidence twice for
imprecision of the estimates.
• Publication bias-we were unable to formally assess
publication bias and so have not downgraded the evidence on
this basis, but readers should be aware that the risk of such bias is
possible.
Potential biases in the review process
We chose to use ’the hand’ as our unit of analysis because all trials
were based on unilateral surgery. Two trials included participants
with bilateral carpal tunnel syndrome (Hansen 2009; Kharwadkar
2005), although each hand was decompressed on separate occa-
sions and therefore, each hand recorded as an individual case. Pre-
vious reviews on topics related to CTS have highlighted the im-
portance of correctly selecting the unit of analysis-’the hand’ versus
’the patient’ (Scholten 2007) and this statistical issue is familiar to
hand surgeons (Sauerland 2003). This is particularly important
when considering the outcomes of interest. For example, the unit
of analysis should arguably be ’the patient’ when satisfaction or
return-to-work are the variables of interest, irrespective of whether
the surgery is unilateral, staged bilateral, or simultaneous bilateral.
Conversely, when one is considering a local phenomenon or com-
plication (which is usually unilateral, such as infection) then we
feel that the unit of analysis should be ’the hand’. More difficult
outcomes are those of pain, inflammation, aesthetics, and func-
tion, as one side is not independent of the other, or the person
in a holistic sense. We would argue that when the unit of analysis
is in doubt (such as for local phenomena or holistic outcomes),
that ’the hand’ should be the unit of analysis in order to better
capture sided differences. We accept that by using ’the hand’ as
the unit of measure, the sample size is artificially inflated, which
will erroneously shrink the standard error of the effect size and
narrow the confidence interval. Also, by using ’the hand’ as the
unit of measure, some statistical tests can no longer be used as the
assumptions of independence are violated. Therefore, researchers
should take great care when selecting their unit of analysis and
seek professional statistical advice when designing their research.
Four trials concerned OCTD via a longitudinal skin incision (3
cm to 4 cm in length, as reported by two studies), whilst Hansen
2009 was based on ECTD through an incision of unknown size
(although we assume that it is smaller than 3 cm). We chose to
include data from the trial on endoscopic surgery because we feel
that operatively, the procedure is sufficiently similar to OCTD
(i.e. whether the incision is 1 cm (for endoscopic surgery) or 3 cm
(for open surgery), both warrant closure with sutures and both are
prone to the adverse outcomes we sought to investigate). Vasiliadis
2014 suggested that outcomes of ECTD andOCTD are different,
as endoscopic surgery carried a lower risk of minor complications
(RR 0.55, 95% CI 0.38 to 0.81, 18 studies) but a higher risk of
transient nerve problems (i.e. neurapraxia, numbness, and paraes-
thesiae) and so they concluded that ECTRwas safer when the total
number of complications were assessed (RR 0.60, 95% CI 0.40
to 90, 20 studies). Therefore, some readers might disagree with
our decision to include data on ECTD. To approach the prob-
lem in a balanced manner, we included data from Hansen 2009
but analysed the trial separately. Future trialists and reviewers may
consider our opinions on this topic in the section Implications for
research.
With hindsight, wound inflammation is a difficult outcome to de-
fine and moreover, it is debatable how important wound inflam-
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mation is in the context of pain, adverse outcomes or hand func-
tion. Wound inflammation is a normal part of the healing process
and judging when this is pathologically is difficult for clinicians
and more complex still for review authors. To handle the hetero-
geneity of outcome measures and time points at which wound in-
flammation was assessed, we elected to dichotomise the outcome,
which certainly introduces difficulties in interpretation. We sug-
gest that authors of future reviews consider whether wound in-
flammation is necessary to consider and if so, how best to handle
these data.
The majority of studies reported pain at 10 days and at 6 weeks
and we also reported these time points in this review (our protocol
specified 48 hours, 48 hours to seven days and more than seven
days). Although the review lacks data from the immediate post-
operative period, this is of less relevance than long-term healing.
As surgical trainees, RGW and JCRW have not formed their pref-
erences for any particular suture type and use the suture preferred
by the consultant in charge of care. AF, a consultant plastic surgeon
and associate professor, uses absorbable 4-0 Vicryl Rapide for his
elective OCTD. However, he has no strong preference and this
systematic review was encouraged and supervised in an unbiased
fashion, in the pursuit of a high-quality research synopsis.
Agreements and disagreements with other
studies or reviews
We identified one other systematic review that considered studies
of absorbable versus non-absorbable sutures for closing the skin
after OCTD. The findings differ from those of our review, in that
the authors’ conclusion was in favour of non-absorbable sutures
(Magalhães 2017). However, limitations in conduct and report-
ing in Magalhães 2017 account for the discrepancy between their
findings and those of this review: the methods, search strategy,
inclusion criteria and outcomes were not fully described and the
authors did not assess the risk of bias or the quality of the evidence.
There was a narrative summary of postoperative pain, infection,
and scar and wound inflammation.but no meta-analysis or mea-
surement of heterogeneity.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
It is uncertain whether there is a difference in pain or wound in-
flammation following use of absorbable and non-absorbable su-
tures for skin closure after carpal tunnel decompression, because
the quality of evidence is very low. We have no evidence of suffi-
cient quality to assist choice of suture following surgery for carpal
tunnel syndrome (CTS). Absorbable sutures eliminate the need
for suture removal and may provide potential time and cost sav-
ings for both patients and healthcare institutions.
Implications for research
We suggest that a non-inferiority randomised controlled trial is
required in order to reliably answer the question of whether ab-
sorbable or non-absorbable sutures should be used for skin clo-
sure after carpal tunnel decompression. Such research should: be
rigorously design by an experienced group of clinicians and aca-
demics; be approved by the appropriate local and national regula-
tory authorities; be registered on open forums; and recruit a rep-
resentative sample. Specifically, we recommend that trialists stan-
dardise the intervention so that the only planned variable is the
suture material (i.e. avoid comparing mattress non-absorbable su-
tures with interrupted absorbable sutures). Such research would
warrant large samples to ensure the research is adequately powered
for uncommon events at a one-tailed level, as per a non-inferiority
trial. Also, researchers should use validated patient-reported and
objective outcome measures and ideally, record pain as a contin-
uous measure (e.g. on a visual analogue scale) as this better allows
transformation, modelling andmeta-analysis than categorical out-
comes. Such a trial should involve a substantial economic analysis
to establish whether eliminating the need for suture removal re-
duces overall costs.
Allocation concealment, andblinding of participants and outcome
assessors are widely accepted as the most important factors in re-
ducing bias (Schultz 1995). We observed substantial risk of bias
in these domains in most of the included studies and so we echo
previous authors in saying that randomised trials relating to carpal
tunnel decompression surgery should follow an agreed format, use
validated outcomemeasures at pre-ordained times and report their
findings according to the CONSORT 2010 guidance (Gerritsen
2002; Jerosch-Herold 2006; Scholten 2007).
Revisions of this review should again seek the complete dataset
from Kundra 2010 and similar research with missing outcome
data.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by year of study]
Erel 2001
Methods Randomised controlled trial
Participants Adults (18 to 80 years old) with carpal tunnel syndrome and open carpal tunnel decom-
pression
64 participants undergoing unilateral CTD recruited over 6 months
The patient was the unit of randomisation
Mean age: not reported
Male to female ratio: not reported
Absorbable group: 32 participants
Non-absorbable group: 32 participants
Interventions Absorbable (Group A): Single subcutaneous 4.0 absorbable braided polyglactin 910 for
deep closure (Vicryl) and continuous subcuticular 4.0 polyglactin 910 (Vicryl) for skin
closure
Non-absorbable (Group B): Non-absorbable interrupted 5.0 monofilament polypropy-
lene (Prolene)
Outcomes 10 days:
1. presence or absence of wound healing, dehiscence, swelling, inflammation,
infection and haematoma (dichotomous)
2. postoperative pain score: 1 (comfortable) 2 (uncomfortable) 3 (very
uncomfortable) 4 (painful) 5 (very painful) (ordinal)
6 weeks:
1. presence or absence of pain (dichotomous)
2. presence or absence of residual inflammation, stiffness and suture extrusion
(polyglactin 910 only) (dichotomous)
3. time off work
Conflicts of interest Not stated
Funding Not stated
Notes Ordinal pain score at 10 days
Dichotomous outcomes at 6 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation method not stated
Allocation concealment (selection bias) High risk Concealment not stated
28Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Erel 2001 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No response from 6 participants (9.4%) at 10 days for
their primary outcome of pain and at least 4 dropouts (6.
3%) at 6 weeks
Selective reporting (reporting bias) High risk Not all outcomes reported numerically
Other bias High risk Conflict of interest, biases (suture preferences) and fund-
ing not stated. The choice of statistical analysis also rep-
resented a possible risk of bias
Menovsky 2004
Methods Randomised controlled trial
Participants Adults (32-80 years old) with electromyography confirmed carpal tunnel syndrome
undergoing unilateral open carpal tunnel decompression
42 patients recruited over 4 months
The patient was the unit of randomisation.
Mean age: 50.4 (range 30 to 82)
Male to female ratio: 14:57
Absorbable group: 25 participants
Non-absorbable group: 17 participants
Interventions Absorbable: Braided 4.0 polyglactin 910 (Vicryl)
Non-absorbable: Monofilament 4.0 nylon (Ethilon)
Steel: 4.0 stainless steel sutures (Ethicon) which was not included in our analysis
Outcomes 10 days:
1. postoperative pain VAS 0 to 100, numbness and tingling (continuous)
2. cosmetic appearance 1 to 4 (ordinal)
3. redness, granuloma and hypertrophy 0-2 (ordinal)
6 weeks:
1. postoperative pain VAS 0 to 100, numbness and tingling (continuous)
2. cosmetic appearance 1 to 4 (ordinal)
3. redness, granuloma and hypertrophy 0-2 (ordinal)
Conflicts of interest Not stated
Funding Not stated
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Menovsky 2004 (Continued)
Notes Postoperative pain (continuous)
Other outcomes (ordinal)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation method not stated
Allocation concealment (selection bias) High risk Allocation not concealed
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Unblinded participants, unblinded (lead) researcher who
was also the operating surgeon
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Assessors blinded when assessing cosmetic outcome but
the lead author and operating surgeon was not blinded
for other outcomes
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data appear complete
Selective reporting (reporting bias) Unclear risk Unable to assess fully as no protocol available
Other bias Unclear risk Conflict of interest, biases (suture preferences) and fund-
ing not stated
Kharwadkar 2005
Methods Randomised controlled trial
Participants Adults (18-75 years old) with symptoms of CTS and open carpal tunnel decompression
Overall, 36 participants were recruited for randomisation and 5 were lost to follow-up
Participants: 31 patients were recruited and randomised over 9 months
Mean age: 51 (range 31-74)
Male to female ratio: 8:25
Absorbable group: 18 participants
Non-absorbable group: 18 participants
Interventions Absorbable: continuous subcuticular technique using braided 3.0 polyglactin 910
(Vicryl)
Non-absorbable: continuous subcuticular technique using 3.0monofilament polypropy-
lene (Prolene)
Outcomes Pre-op:
1. carpal tunnel syndrome symptom severity score (CTS-SSS) and carpal tunnel
syndrome functional status scale (CTS-FSS)
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Kharwadkar 2005 (Continued)
2 weeks:
1. scar tenderness (none, mild, moderate, severe)
2. wound inflammation (1 = < 25%, 2 = 25%, 3 = 50%-75%, 4 = 75%-100%)
3. pillar pain (VAS 0-10)
4. carpal tunnel syndrome symptom severity score (CTS-SSS) and carpal tunnel
syndrome functional status scale (CTS-FSS)
6 weeks:
1. scar tenderness (none, mild, moderate, severe)
2. wound inflammation (1 = < 25%, 2 = 25%, 3 = 50%-75%, 4 = 75%-100%)
3. pillar pain (VAS 0-10)
4. carpal tunnel syndrome symptom severity score (CTS-SSS) and carpal tunnel
syndrome functional status scale (CTS-FSS)
12 weeks:
1. scar tenderness (none, mild, moderate, severe)
2. wound inflammation (1 = < 25%, 2 = 25%, 3 = 50-75%, 4 = 75-100%)
3. pillar pain (VAS 0-10)
4. carpal tunnel syndrome symptom severity score (CTS-SSS) and carpal tunnel
syndrome functional status scale (CTS-FSS)
Conflicts of interest Not stated
Funding Not stated
Notes Postoperative pain (continuous)
Wound inflammation and scar tenderness (ordinal)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated sequence
Allocation concealment (selection bias) Low risk Sealed envelope technique
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not clearly stated
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Assessor independent from surgical team (blinding im-
plied)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data appear to be complete
Selective reporting (reporting bias) Unclear risk Unable to assess fully as no protocol available
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Kharwadkar 2005 (Continued)
Other bias Unclear risk Conflict of interest, biases (suture preferences) and fund-
ing not stated
Hansen 2009
Methods Randomised controlled trial
Participants Electromyography confirmed carpal tunnel with endoscopic (minimally invasive) carpal
tunnel decompression
58 hands (belonging to 50 patients) recruited over 7 months (54 hands followed up)
The hand was the unit of randomisation and analysis
Mean age: 48 years (21-70)
Male to female ratio: 14:36
Absorbable group: 28 participants
Non-absorbable group: 26 participants
Interventions Absorbable: continuous absorbable subcuticular 4/0 monofilament polyglytone 6211
(Caprosyn) (28 hands available for analysis)
Non-absorbable: Two interrupted sutures of non-absorbable 5.0 monofilament poly-
butester (Novafil) (26 hands available for analysis)
Outcomes 10-14 days (suture removal):
1. postoperative pain: VAS 0-10 over 14 days, recorded daily
2. postoperative infection
3 months:
1. cosmetic result (verbal rating scale 1-5)
Conflicts of interest None
Funding Unfunded
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Details of the randomisation sequence insufficient to
form a judgement
Allocation concealment (selection bias) Unclear risk Sealed envelopes were opened by an operating theatre
nurse, although we do not know if these envelopes were
opaque or sequentially numbered
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not stated whether participants were blinded. Personnel
not blinded
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Hansen 2009 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The cosmetic appearance questionnaire was completed
by participants and then put into a sealed envelope; it is
unclear if participants were blinded. Also, it is unclear if
the nurse removing the sutures was the same as the nurse
assessing the outcome of infection. Analysis of these data
was by personnel who were not blinded to the interven-
tion (grouping)
Incomplete outcome data (attrition bias)
All outcomes
Low risk “One patient was withdrawn from the study because the
operation was cancelled as the symptoms had sponta-
neously regressed. Two patients were withdrawn because
their operation was converted to an open release, and
one patient dropped out after operation because of her
inability to attend the follow-up appointments. As a re-
sult, 54 hands were available for follow-up”. Dropouts
apparently at random
Selective reporting (reporting bias) Unclear risk Data not tabulated so difficult to fully assess. Wound
inflammation and suture granulomas reported in results
but assessments were not reported as described in meth-
ods
Other bias Low risk Professor Hansen clarified that there were no conflicts of
interest, the trial was unfunded and the authors’ personal
suture preference (practice prior to the trial) was to use
Novafil, a non-absorbable suture
Theopold 2012
Methods Randomised controlled trial
Participants All patients attending for elective unilateral open carpal tunnel decompression
38 patients were recruited and randomised (unknown recruitment period)
Mean age (absorbable):57.9
Male to female ratio (absorbable): 5:13
Mean age (non-absorbable): 52.9
Male to female ratio (non-absorbable): 10:10
Absorbable group: 18 participants
Non-absorbable group: 20 participants
Interventions Absorbable: Braided Vicryl Rapide 4.0 (simple interrupted sutures)
Non-absorbable: Monofilament Novafil 4.0 (simple interrupted sutures)
Outcomes 5 days:
1. postoperative infection (prescribed antibiotics)
2. 14 days (suture removal)
3. postoperative pain (0 to 10, NRS)
6 weeks:
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Theopold 2012 (Continued)
1. scar assessment (modified Patient and Observer Scar Assessment Scale, POSAS)
Conflicts of interest None
Funding None
Notes Postoperative pain (continuous)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of random generation sequence not stated
Allocation concealment (selection bias) Low risk Sealed envelope technique
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded for any outcome
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Whilst assessors were blind to grouping for 6-week out-
comes, all other outcomes were patient-reported out-
comes with unblinded participants, so we judged this
study at high risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 19% attrition rate
Selective reporting (reporting bias) Unclear risk Unable to assess fully as no protocol available
Other bias Unclear risk Conflicts of interest given as “None declared”, The trial
received no special funding. No biases or suture prefer-
ences declared
CTD: carpal tunnel decompression
NRS: numerical rating scale
VAS: visual analogue scale
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Characteristics of excluded studies [ordered by year of study]
Study Reason for exclusion
Dellon 2001 Letter to the editor regarding Erel 2001
Zingale 2003 Case report
Jerosch-Herold 2006 A systematic review of outcomes for carpal tunnel surgery. Not a comparison of suture type
Hung 2008 Case report of median nerve conduit
Kundra 2010 A randomised trial evaluating the aesthetic outcomes of patients undergoing elective day-case hand and wrist
surgery (including some patients undergoing carpal tunnel decompression). We contacted the authors but
they were unable to provide the original data or subgroup analyses of the carpal tunnel
Freshwater 2012 A letter to the Editor regarding Theopold 2012
Scholten 2012 Systematic review of surgical techniques for carpal tunnel - not comparison of suture material
Acioly 2013 Case report describing mini-open decompression technique
Dosani 2013 Clinical outcome and cost comparison of carpal tunnel wound closure with Monocryl and Ethilon - a
prospective study but not randomised
Bolster 2013 Trial of interrupted versus vertical mattress sutures
Nassar 2014 A case series describing the use of a synthetic biofilm applied to a decompressed median nerve to prevent
neural adhesions. No data on suture use or outcomes
MacFarlane 2014 A prospective study comparing the clinical outcomes and wound healing following carpal tunnel decompres-
sion using two different suture materials but not a randomised trial
Kokkalis 2015 Case series (two patients) reporting NeuraWrap collagen nerve protectors for revision median nerve decom-
pression in an effort to reduce latent scarring
Lattré 2016 Case series concerning the hypothenar fat pad flap
Kokkalis 2016 Case series of nerve wraps
Lu 2017 Case report of CTS due to tophaceous gout
Tosti 2017 Case series of catheter-associated radial artery pseudoaneurysms
Ramos-Zúñiga 2017 Case series of ECTD
Magalhães 2017 Systematic review of absorbable versus non-absorbable sutures following CTD
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CTD: carpal tunnel decompression
CTS: carpal tunnel syndrome
ECTD: endoscopic carpal tunnel decompression
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D A T A A N D A N A L Y S E S
Comparison 1. Absorbable versus non-absorbable sutures: open endoscopic carpal tunnel decompression (CTD)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Postoperative pain (10 days)
after CTD
3 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
2 Postoperative pain (6 weeks)
after CTD
4 175 Std. Mean Difference (IV, Random, 95% CI) 0.06 [-0.72, 0.84]
3 Postoperative hand function
(BCQ-FSS) after CTD
1 Mean Difference (IV, Random, 95% CI) Subtotals only
3.1 2 weeks 1 36 Mean Difference (IV, Random, 95% CI) -0.10 [-0.53, 0.33]
3.2 6 weeks 1 36 Mean Difference (IV, Random, 95% CI) 0.0 [-0.39, 0.39]
3.3 12 weeks 1 36 Mean Difference (IV, Random, 95% CI) 0.0 [-0.37, 0.37]
4 Wound inflammation 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
Comparison 2. Absorbable versus non-absorbable sutures: endoscopic carpal tunnel decompression (CTD)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Postoperative pain (10 days)
after CTD
1 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
2 Wound inflammation 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
3 Scar satisfaction (scar assessed
as ’nice’) by participant after
endoscopic CTD
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
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Analysis 1.1. Comparison 1 Absorbable versus non-absorbable sutures: open endoscopic carpal tunnel
decompression (CTD), Outcome 1 Postoperative pain (10 days) after CTD.
Review: Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery
Comparison: 1 Absorbable versus non-absorbable sutures: open endoscopic carpal tunnel decompression (CTD)
Outcome: 1 Postoperative pain (10 days) after CTD
Study or subgroup Absorbable Non-absorbable
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD)[1] N Mean(SD)[1] IV,Random,95% CI IV,Random,95% CI
Erel 2001 30 1.6 (1.8) 28 1.8 (0.9) -0.14 [ -0.65, 0.38 ]
Kharwadkar 2005 18 1.6 (1.5) 19 2 (1.4) -0.27 [ -0.92, 0.38 ]
Menovsky 2004 25 3.1 (2.3) 17 1.9 (2.3) 0.51 [ -0.11, 1.14 ]
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours absorbable Favours non-absorbable
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Analysis 1.2. Comparison 1 Absorbable versus non-absorbable sutures: open endoscopic carpal tunnel
decompression (CTD), Outcome 2 Postoperative pain (6 weeks) after CTD.
Review: Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery
Comparison: 1 Absorbable versus non-absorbable sutures: open endoscopic carpal tunnel decompression (CTD)
Outcome: 2 Postoperative pain (6 weeks) after CTD
Study or subgroup Absorbable Non-absorbable
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD)[1] N Mean(SD)[1] IV,Random,95% CI IV,Random,95% CI
Erel 2001 30 1.6 (0.5) 28 1.3 (0.5) 26.2 % 0.59 [ 0.06, 1.12 ]
Kharwadkar 2005 18 0.3 (0.6) 19 1.9 (1.9) 24.1 % -1.10 [ -1.80, -0.40 ]
Menovsky 2004 25 3.4 (2.6) 17 3.6 (3.1) 25.1 % -0.07 [ -0.69, 0.55 ]
Theopold 2012 18 1.3 (2) 20 0.2 (0.4) 24.5 % 0.77 [ 0.10, 1.43 ]
Total (95% CI) 91 84 100.0 % 0.06 [ -0.72, 0.84 ]
Heterogeneity: Tau2 = 0.53; Chi2 = 18.84, df = 3 (P = 0.00030); I2 =84%
Test for overall effect: Z = 0.15 (P = 0.88)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours absorbable Favours non-absorbable
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Analysis 1.3. Comparison 1 Absorbable versus non-absorbable sutures: open endoscopic carpal tunnel
decompression (CTD), Outcome 3 Postoperative hand function (BCQ-FSS) after CTD.
Review: Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery
Comparison: 1 Absorbable versus non-absorbable sutures: open endoscopic carpal tunnel decompression (CTD)
Outcome: 3 Postoperative hand function (BCQ-FSS) after CTD
Study or subgroup Absorbable Non-absorbable
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 2 weeks
Kharwadkar 2005 18 1.5 (0.56) 18 1.6 (0.73) 100.0 % -0.10 [ -0.53, 0.33 ]
Subtotal (95% CI) 18 18 100.0 % -0.10 [ -0.53, 0.33 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.46 (P = 0.64)
2 6 weeks
Kharwadkar 2005 18 1.3 (0.21) 18 1.3 (0.81) 100.0 % 0.0 [ -0.39, 0.39 ]
Subtotal (95% CI) 18 18 100.0 % 0.0 [ -0.39, 0.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
3 12 weeks
Kharwadkar 2005 18 1.1 (0.39) 18 1.1 (0.69) 100.0 % 0.0 [ -0.37, 0.37 ]
Subtotal (95% CI) 18 18 100.0 % 0.0 [ -0.37, 0.37 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
-1 -0.5 0 0.5 1
Favours absorbable Favours non-absorbable
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Analysis 1.4. Comparison 1 Absorbable versus non-absorbable sutures: open endoscopic carpal tunnel
decompression (CTD), Outcome 4 Wound inflammation.
Review: Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery
Comparison: 1 Absorbable versus non-absorbable sutures: open endoscopic carpal tunnel decompression (CTD)
Outcome: 4 Wound inflammation
Study or subgroup Absorbable Non-absorbable Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Erel 2001 11/31 2/28 4.97 [ 1.20, 20.50 ]
Kharwadkar 2005 18/18 15/18 1.19 [ 0.95, 1.50 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 2.1. Comparison 2 Absorbable versus non-absorbable sutures: endoscopic carpal tunnel
decompression (CTD), Outcome 1 Postoperative pain (10 days) after CTD.
Review: Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery
Comparison: 2 Absorbable versus non-absorbable sutures: endoscopic carpal tunnel decompression (CTD)
Outcome: 1 Postoperative pain (10 days) after CTD
Study or subgroup Absorbable Non-absorbable
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD)[1] N Mean(SD)[1] IV,Random,95% CI IV,Random,95% CI
Hansen 2009 28 1 (0.5) 26 1.9 (1.5) -0.81 [ -1.36, -0.25 ]
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Absorbable versus non-absorbable sutures: endoscopic carpal tunnel
decompression (CTD), Outcome 2 Wound inflammation.
Review: Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery
Comparison: 2 Absorbable versus non-absorbable sutures: endoscopic carpal tunnel decompression (CTD)
Outcome: 2 Wound inflammation
Study or subgroup Absorbable Non-absorbable Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Hansen 2009 1/28 1/26 0.93 [ 0.06, 14.09 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 2.3. Comparison 2 Absorbable versus non-absorbable sutures: endoscopic carpal tunnel
decompression (CTD), Outcome 3 Scar satisfaction (scar assessed as ’nice’) by participant after endoscopic
CTD.
Review: Absorbable versus non-absorbable sutures for skin closure after carpal tunnel decompression surgery
Comparison: 2 Absorbable versus non-absorbable sutures: endoscopic carpal tunnel decompression (CTD)
Outcome: 3 Scar satisfaction (scar assessed as ’nice’) by participant after endoscopic CTD
Study or subgroup Absorbable Non-absorbable Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Hansen 2009 25/28 18/26 1.29 [ 0.97, 1.72 ]
Test for subgroup differences: Not applicable
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A P P E N D I C E S
Appendix 1. Cochrane Neuromuscular Specialised Register (CRSW) search strategy
#1 “carpal tunnel” AND INREGISTER
#2 (“nerve entrapment” or “nerve compression” or “entrapment neuropathy” or “entrapment neuropathies”) and carpal AND INREG-
ISTER
#3 #1 or #2 AND INREGISTER
#4 absorbable or nonabsorbable or “non absorbable” or biodegradable AND INREGISTER
#5 #3 and #4 AND INREGISTER
Appendix 2. Cochrane Central Register of Controlled Trials (CENTRAL) (CRSW) search strategy
#1 “carpal tunnel” AND CENTRAL:TARGET
#2 (“nerve entrapment” or “nerve compression” or “entrapment neuropathy” or “entrapment neuropathies”) and carpal AND CEN-
TRAL:TARGET
#3 #1 or #2 AND CENTRAL:TARGET
#4 absorbable or nonabsorbable or “non absorbable” or biodegradable AND CENTRAL:TARGET
#5 #3 and #4 AND CENTRAL:TARGET
Appendix 3. MEDLINE (OvidSP) search strategy
Database: Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily, Ovid
MEDLINE and Versions(R)
Ovid MEDLINE(R) Daily Update October 27, 2017
Search Strategy:
--------------------------------------------------------------------------------
1 carpal tunnel.mp. (10841)
2 ((nerve entrapment or nerve compression or entrapment neuropath*) and carpal).mp. (1351)
3 1 or 2 (10914)
4 (absorbable or nonabsorbable or non absorbable or biodegradable).mp. (38630)
5 3 and 4 (17)
6 remove duplicates from 5 (16)
Appendix 4. Embase (OvidSP) search strategy
Database: Embase <1980 to 2017 Week 44>
Search Strategy:
--------------------------------------------------------------------------------
1 carpal tunnel.mp. (14628)
2 ((nerve entrapment or nerve compression or entrapment neuropath*) and carpal).mp. (2213)
3 1 or 2 (14690)
4 exp absorbable suture/ (4464)
5 exp nonabsorbable suture/ (3868)
6 (absorbable or nonabsorbable or non absorbable or biodegradable).mp. (45805)
7 or/4-6 (49678)
8 3 and 7 (23)
9 limit 8 to (conference abstracts or embase) (16)
10 remove duplicates from 9 (16)
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C O N T R I B U T I O N S O F A U T H O R S
RGW: identified need for review on this topic and preliminary review of available evidence.
RGW and JCRW: developed protocol.
AF: provided clinical input.
JCRW: provided methodology input and developed initial search strategy alongside AAG.
The authors completed this review within their own time, as there is no allocated time or funding for such activities within their job
plans.
TASK WHO HAS AGREED TO UNDERTAKE THE TASK?
Draft the protocol Ryckie G Wade, Justin CR Wormald
Develop criteria for a search strategy (in conjunction with the
Trials Search Co-ordinator)
Justin CR Wormald
Search identified titles and abstracts for trials (usually 2 people) Ryckie G Wade, Justin CR Wormald
Obtain copies of trials All review authors
Select which trials to include (2 + 1 arbiter) All review authors
Extract data from trials (2 people) Justin Wormald, Ryckie G Wade
Enter data into RevMan (1 + 1 to check) Justin CR Wormald, Ryckie G Wade
Carry out the analysis Justin CR Wormald
Develop ’Summary of findings’ tables Justin CR Wormald, Ryckie G Wade
Interpret the analysis All review authors
Draft the final review All review authors
Update the review Ryckie G Wade, Justin CR Wormald
D E C L A R A T I O N S O F I N T E R E S T
RGW: none
JCRW: none
AF: none
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S O U R C E S O F S U P P O R T
Internal sources
• NIHR Academic Clinical Fellowship, UK.
Ryckie G Wade is an Academic Clinical Fellow in Plastic Surgery, funded by the National Institute for Health Research. He
conducted part of this review during this fellowship,
• None, Other.
Justin Wormald and Andrea Figus complete this review within their own time, as there is no allocated time or funding for such
activities within their jobs plans. Ryckie Wade began this review in his own time, but later used the above fellowship time to complete
the works.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
1. Our protocol described using primary data from studies on “open or minimally invasive carpal tunnel decompression surgery”
and accordingly, we included one trial on ECTD because this is a form of minimally invasive surgery. The incision(s) required for
ECTD are slightly smaller, and sometimes two incisions are required. Because such incisions warrant closure with a suture and the
participants, methods and outcomes are sufficiently similar, we chose to include the ECTD data, but presented the data separately.
2. We intended to define postoperative pain as: short term (first 48 hours postoperatively), medium term (48 hours to seven days
postoperatively) and long term (more than seven days postoperatively). However, following review of the included literature, we
found that the majority of studies reported pain at 10 days and at 6 weeks and so we have deviated from protocol in order to report
these outcomes at time points which both reflected the original data and enabled us to perform a meta-analysis.
3. In general, outcome reporting was not as extensive as we had expected and so we were largely limited to reporting postoperative
pain and wound inflammation, with the one ECTD trial reporting hand function and-on an ordinal, probably nonvalidated scale-
scar satisfaction. Our protocol described secondary outcomes including: 1) postoperative hand function, e.g. as measured by the
validated Disabilities of the Arm, Shoulder and Hand questionnaire, 2) scar satisfaction, e.g. as measured by the validated Vancouver
Scar Scale, and 3) postoperative adverse events. Adverse events were not reported in any of the included studies and so we are unable
to investigate them.
4. We included five studies so did not produce a funnel plot to investigate publication bias.
5. We changed the title of the review in order to better describe the nature of the intervention under scrutiny.
6. We added scar inflammation as a secondary outcome because this was reported in two trials and we felt would be supplement
the secondary outcomes (particularly scar satisfaction) which we could not fully assess owing to insufficient primary data.
7. We planned to carry out subgroup analyses stratified by: 1) disease severity of carpal tunnel syndrome, and 2) medical
comorbidity, but these data were not reported in the primary trials so could not be undertaken.
8. We followed guidance in the Cochrane Handbook for Systematic Reviews of Interventions for rule of thumb interpretation of SMD
and I2 (Deeks 2011; Higgins 2011).
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